Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Labetalol vs Phentolamine for Severe Preeclampsia
NCT06385600Not yet recruiting
- Sponsor
- Assiut University
- Start
- May 2024
- Primary completion
- Jan 2026
- Modality
- Small Molecules
01
Overview
Randomised trial of phentolamine in severe preeclampsia (2 arms), sponsored by Assiut University. Primary endpoint: Middle Cerebral Artery flow velocity at 6 hours. Planned start May 2024; status: not yet recruiting.
02
Drugs
phentolamine
03
Conditions
severe preeclampsia
Beyond the preview
Go deeper on NCT06385600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06385600.